Addex Therapeutics Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
28.56 M |
Public Float |
- |
Addex Therapeutics Ltd. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF0.05 |
Market Cap |
CHF46.5 M |
Shares Outstanding |
32.85 M |
Public Float |
19.3 M |
Address |
12, Chemin des Aulx Geneva Geneve (Geneva) 1228 Switzerland |
Employees | - |
Website | http://www.addextherapeutics.com |
Updated | 07/08/2019 |
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland. |